1 – 10 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Healthcare Resource Utilisation in Patients with Upper Tract Urothelial Carcinoma : Healthcare
- Contribution to journal › Article
-
Mark
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner
- Contribution to journal › Article
-
Mark
Lymph node surgery after centralization of penile cancer care in Sweden : Extent of use and complications
- Contribution to journal › Article
-
Mark
Secondary Colonic Adenocarcinoma After Continent Cutaneous Urinary Diversion a.m. Lundiana—An Aggressive Disease Entity With High Risk of Locally Advanced Disease and Metastases
- Contribution to journal › Article
-
Mark
Long-Term Outcomes After Laparoscopy-Assisted Cryoablation for Renal Cell Carcinoma-Results From a Single-Center Series
- Contribution to journal › Article
-
Mark
Evaluating 18F-FDG PET-CT for Regional Lymph Node Assessment in Advanced Upper Tract Urothelial Carcinoma
- Contribution to journal › Article
-
Mark
Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer
- Contribution to journal › Article
-
Mark
Stage-Independent Real-Time Subtype Classification and Comprehensive Biopsy Profiling of Urothelial Carcinomas by the Lund Taxonomy System
- Contribution to journal › Article
-
Mark
First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma—commentary on patient-reported outcomes in EV-302
- Contribution to journal › Debate/Note/Editorial
- 2025
-
Mark
The association between animal protein, plant protein, and their substitution with bladder cancer risk : a pooled analysis of 10 cohort studies
- Contribution to journal › Article
